ASCEND BY NTHRYS
Research Abroad Products

Immunotechnology Project Topics

Browse all focused areas across all project categories under this field.

Showing 13–24 of 200 project topics
CAR-T Vector Design and Optimization SaaS Platform
An AI-driven design platform that rapidly generates optimized CAR constructs, costimulatory domain combinations, and transgene configurations tailored to specific cancer indications and patient populations. This accelerates time-to-clinic for proprietary CAR-T programs, reduces R&D spending, and enables licensing opportunities for optimized vector designs to pharmaceutical partners.
CAR-T Cell Therapy Technology Development Click to view more details →
Clinical CAR-T Patient Management and Monitoring System
An integrated digital health platform that tracks CAR-T infused patients through electronic health records, cytokine release syndrome monitoring, dose-level management, and long-term persistence surveillance with predictive alerting. This improves patient safety outcomes, reduces hospital readmissions, and enables pharmaceutical companies to build real-world evidence datasets for post-market surveillance and label expansion.
CAR-T Cell Therapy Technology Development Click to view more details →
Allogenic Off-the-Shelf CAR-T Cell Banking and Logistics Service
A commercial cell banking and cold-chain logistics service that manufactures, cryopreserves, and distributes pre-manufactured allogeneic CAR-T cell products on-demand to treatment centers globally. This eliminates patient-specific manufacturing delays, reduces per-dose production costs by 70%, and creates a recurring revenue stream through subscription-based cell product delivery.
CAR-T Cell Therapy Technology Development Click to view more details →
CAR-T Immunogenicity and HLA Mismatch Prediction Software
A genomic analysis tool that predicts patient HLA-CAR interactions, potential graft-versus-host responses, and immunogenicity risks before CAR-T manufacturing or infusion using machine learning models. This enables personalized patient selection and CAR design optimization, reducing treatment failures, and supporting biomarker-driven precision medicine pricing strategies.
CAR-T Cell Therapy Technology Development Click to view more details →
Automated CAR-T Cell Quality Control and Regulatory Compliance Toolkit
An integrated software suite that automates identity, purity, potency, sterility, and endotoxin testing workflows with real-time data capture, automated reporting, and regulatory submission documentation for CAR-T manufacturing. This reduces quality assurance timelines by 30%, ensures consistent FDA/EMA compliance, and enables faster commercial lot releases and shipping.
CAR-T Cell Therapy Technology Development Click to view more details →
Multi-Specific CAR-T Construct Combinatorial Library Design Tool
A computational design platform that generates libraries of dual-antigen targeting CAR-T constructs and tests virtual combinatorial strategies against tumor heterogeneity and antigen escape scenarios. This accelerates development of next-generation CAR-T therapies, reduces preclinical testing costs, and enables IP portfolio expansion through novel construct licensing.
CAR-T Cell Therapy Technology Development Click to view more details →
CAR-T Manufacturing Capacity Planning and Supply Chain Optimization Engine
A demand-forecasting and production scheduling platform that optimizes CAR-T manufacturing capacity, leukapheresis scheduling, cell transport logistics, and inventory management across multiple treatment centers and manufacturers. This maximizes manufacturing asset utilization, reduces cell waste by 25%, and enables contract manufacturers to increase revenue per facility by 40-50%.
CAR-T Cell Therapy Technology Development Click to view more details →
CAR-T Efficacy Prediction and Personalized Dosing Decision Support Tool
A clinical decision-support platform that integrates patient baseline biomarkers, tumor burden metrics, and CAR-T manufacturing parameters to predict response probability and recommend optimal infusion dose schedules. This improves clinical outcomes, reduces over-dosing toxicity events, and enables pharmaceutical sponsors to establish value-based pricing and reimbursement models tied to efficacy predictions.
CAR-T Cell Therapy Technology Development Click to view more details →
High-Throughput ELISA Automation Platform for Diagnostics
A fully integrated robotic ELISA system with AI-driven sample processing and real-time quality control software for clinical laboratories. This platform reduces turnaround time by 60% and increases testing capacity, generating revenue through hardware licensing, consumable sales, and SaaS subscriptions for lab management.
Immunoassay Technology Commercial Development Click to view more details →
Multiplex Immunoassay-as-a-Service Cloud Platform
A cloud-based SaaS platform enabling laboratories and pharmaceutical companies to design, validate, and deploy custom multiplex immunoassays without owning expensive equipment. Revenue streams include per-test fees, subscription tiers based on assay volume, and premium analytics modules for biomarker discovery.
Immunoassay Technology Commercial Development Click to view more details →
Point-of-Care Immunoassay Device with Connected IoT
A portable, smartphone-connected immunoassay device delivering clinical-grade results in under 15 minutes for rapid diagnostics in remote or resource-limited settings. Monetization occurs through device sales, consumable cartridges, cloud data storage, and partnerships with telemedicine platforms.
Immunoassay Technology Commercial Development Click to view more details →
Lateral Flow Immunoassay Manufacturing Optimization Software
An AI-powered SaaS tool that optimizes lateral flow test production parameters, predicts yield rates, and ensures regulatory compliance across manufacturing facilities. It delivers value through reduced manufacturing waste, faster time-to-market for new tests, and licensing fees from diagnostic manufacturers.
Immunoassay Technology Commercial Development Click to view more details →